Alpha Teknova (TKNO) Cash & Equivalents (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Cash & Equivalents came in at $4.3 million in Q1 2026, up 27.51% year-on-year from $3.4 million in Q1 2025, and down 27.17% on a QoQ basis from $5.9 million in Q4 2025.
Alpha Teknova (TKNO) Cash & Equivalents (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Cash & Equivalents data on file, last reported at $4.3 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents rose 27.51% year-over-year to $4.3 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 27.51% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, up 59.44% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $4.3 million, down from $5.9 million in the prior quarter.
- Over the last five years, Cash & Equivalents for TKNO reached as high as $76.5 million in Q1 2022 and fell as low as $3.2 million in Q3 2025.
- Historically, Cash & Equivalents has averaged $24.6 million across 5 years, with a median of $21.6 million in 2024.
- Across the five-year window, Cash & Equivalents jumped 428.52% in 2022 and tumbled 86.98% in 2024, its largest moves.
- Year by year, Cash & Equivalents stood at $42.2 million in 2022, then sank by 32.56% to $28.5 million in 2023, then tumbled by 86.98% to $3.7 million in 2024, then soared by 59.44% to $5.9 million in 2025, then fell by 27.17% to $4.3 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $4.3 million in Q1 2026, $5.9 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.76 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.79 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.28 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 266.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 4.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.31 Mn |
| Dec 31, 2025 | 5.91 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.28 Mn |
| Mar 31, 2025 | 3.38 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 6.15 Mn |
| Jun 30, 2024 | 18.60 Mn |
| Mar 31, 2024 | 21.60 Mn |
| Dec 31, 2023 | 28.48 Mn |
| Sep 30, 2023 | 32.10 Mn |
| Jun 30, 2023 | 23.71 Mn |
| Mar 31, 2023 | 30.20 Mn |
| Dec 31, 2022 | 42.24 Mn |
| Sep 30, 2022 | 49.86 Mn |
| Jun 30, 2022 | 64.73 Mn |
| Mar 31, 2022 | 76.46 Mn |
| Dec 31, 2021 | 87.52 Mn |
| Sep 30, 2021 | 98.01 Mn |
| Jun 30, 2021 | 108.02 Mn |